全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Yu-Jeong Choi , Youn Kyung Choi , Kang Min Lee ...
来源:[J].BMC Complementary and Alternative Medicine(IF 2.082), 2016, Vol.16 (1)Springer
摘要:...(#br) Methods(#br)SH003 extract in 30% ethanol was used to treat the prostate cancer cell lines DU145, LNCaP, and PC-3. Cell viability was determined by MTT and BrdU incorporation assays. Next, apoptotic cell death was determined by Annexin V and 7-AAD double staining methods...
作者:Linjie Chen , Dennis W. Wolff , Yan Xie ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Virtually all prostate cancer deaths occur due to obtaining the castration-resistant phenotype after prostate cancer cells escaped from apoptosis and/or growth suppression initially induced by androgen receptor blockade. TNF-related apoptosis-inducing ligand (TRAIL) was an attrac...
作者:Wonil Koh , Kwang Seok Ahn , Soo-Jin Jeong ...
来源:[J].Chinese Science Bulletin(IF 1.319), 2010, Vol.55 (34), pp.3922-3928Springer
摘要:... In the present study, we investigated the mechanisms whereby isothiocyanate sulforaphane (SFN) suppresses STAT3 activation in DU145 prostate cancer cells. SFN significantly inhibited SFN-inhibited STAT3 phosphorylation at Tyr705 as well as the deoxyribonucleic acid (DNA) bind...
作者:Pushkar Saralkar , Alekha K. Dash
来源:[J].AAPS PharmSciTech(IF 1.584), 2017, Vol.18 (7), pp.2814-2823Springer
摘要:... Alginate nanoformulation was tested for in vitro efficacy on DU145 prostate cancer cells. The particle size of the nanosuspension and freeze-dried nanoparticles was found to be 12.53 ± 1.06 and 60.23 ± 15 nm, respectively. Both DSC and powder XRD studies indicated that c...
作者:K. A. Fomicheva , A. I. Osip’yants , E. N. Knyazev ...
来源:[J].Bulletin of Experimental Biology and Medicine(IF 0.341), 2017, Vol.162 (6), pp.792-796Springer
摘要:We studied the profile of miRNA secreted into culture medium by DU145 prostate cancer cells and identified a subset of miRNAs characterized by the absence of correlation of their content in the cell and medium, which is likely a result of specific secretion. Three of these miRNA,...
作者:Agnieszka Bojko , Kinga Reichert , Anna Adamczyk ...
来源:[J].Folia Histochemica et Cytobiologica(IF 1.101), 2012, Vol.50 (2), pp.186-195DOAJ
摘要:We employed two selective EGFR tyrosine kinase inhibitors: AG494 (reversible) and AG1478 (irreversible) for growth regulation of human lung (A549) and prostate (DU145) cancer cell lines, cultured in chemically defined DMEM/F12 medium. Both tested tyrphostins significantly inh...
作者:Ran Kang , Shankun Zhao , Luhao Liu ...
来源:[J].Cancer Cell International(IF 2.093), 2016, Vol.16 (1)Springer
摘要:... In this study, we investigated the effects of knocking down the PSCA on the cell migration, the invasiveness, and the EMT of the PCa cell line DU145 in vitro and in vivo.(#br) Methods(#br)Four target sequences of the small hairpin RNA for PSCA were designed, and the best e...
作者:Yanan Sun , Xiaopeng Jia , Lianguo Hou ...
来源:[J].Lipids in Health and Disease(IF 2.015), 2017, Vol.16 (1)Springer
摘要:Present study aimed to better understand the potential apoptotic pathways that involved in docosahexaenoic acid (DHA)-induced apoptosis of prostate cancer cells.
作者:Zhong Lu , Li Qi , Gui-xin Li ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2015, Vol.11 (4), pp.840-845DOAJ
摘要:...Aims: This study is to explore whether MSC induces apoptosis in prostate cancer (PCa) cells DU145 through connexin 43 (Cx43) activation.Settings and Design: The experiment was performed in a PCa cell line model DU145 and using a series of biological assay methods to investiga...
作者:Onyinye Nwagbara , Selina F. Darling-Reed , Alicia Tucker ...
来源:[J].International Journal of Environmental Research and Public Health(IF 1.998), 2007, Vol.4 (1), pp.10DOAJ
摘要:... In this study, the effects of this carcinogen/mutagen and one of its metabolites, benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE), on human prostate carcinoma cell line DU145, were examined. Cell viability, DNA damage, and cell cycle progression were evaluated as toxic end-points...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×